FindTrial
Sign In

Exploration of the Factors Influencing Intraoperative Bleeding in Patients with Cesarean Scar Ectopic Pregnancy Based on Machine Learning, Construction of Classic Machine Learning Predictive Models for Interpretation and Analysis, and Analysis of Pregnancy Outcomes after Scar Ectopic Pregnancy Surgical Treatment in Different Clinical Classifications

Exploration of the Factors Influencing Intraoperative Bleeding in Patients with Cesarean Scar Ectopic Pregnancy Based on Machine Learning, Construction of Classic Machine Learning Predictive Models for Interpretation and Analysis, and Analysis of Pregnancy Outcomes after Scar Ectopic Pregnancy Surgical Treatment in Different Clinical Classifications.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080710
Enrollment
Unknown
Registered
2024-02-05
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Scar Ectopic Pregnancy

Interventions

Intraoperative blood loss = 300mL:none
Intraoperative blood loss < 300mL:none

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Patients with primary cesarean scar pregnancy who are over 18 years old. (2) Singleton pregnancy with a gestational age of =12 weeks. (3) Patients who voluntarily choose surgical treatment. (4) Patients who can comply with postoperative follow-up. (5) Subjects (or their legal representatives) must understand the nature of the study and sign an informed consent form. (6) According to the criteria of the Qilu Clinical Practical Classification (Qilu Classification).

Exclusion criteria

Exclusion criteria: (1) Patients who have received pre-treatments such as medical therapy, uterine artery embolization, or curettage. (2) Patients who cannot exclude ectopic pregnancy or gestational trophoblastic disease. (3) Patients who cannot tolerate surgery. (4) Patients with concomitant malignant tumors.

Design outcomes

Primary

MeasureTime frame
ultrasound findings;surgical information;pregnancy outcome;—

Secondary

MeasureTime frame
Baseline Data;blood markers;—

Countries

China

Contacts

Public ContactCui Baoxia

Qilu Hospital of Shandong University

cuibaoxia@sdu.edu.cn+86 185 6008 1862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026